Identifying pathogenic processes by integrating microarray data with prior knowledge

Ståle Nygård1, Trond Reitan, Trevor Clancy

  • 1Bioinformatics Core Facility, Institute for Medical Informatics, Oslo University Hospital, Oslo, Norway. staaln@ifi.uio.no.

BMC Bioinformatics
|April 25, 2014
PubMed
Abstract

Insights

This study introduces a new Bayesian method to identify functional gene groups from microarray data, improving disease pathway discovery. The approach reveals known pathogenic processes and novel molecular connections for better disease understanding.

Area of Science:

  • Bioinformatics
  • Systems Biology
  • Computational Biology

Background:

  • Identifying molecular pathways in disease etiology is crucial but challenging.
  • High-throughput methods often yield gene sets with poor overlap to known disease pathways.
  • Understanding molecular processes underlying disease progression requires novel analytical approaches.

Purpose of the Study:

  • To present a novel Bayesian statistical method for identifying functional molecular groups from differentially expressed genes.
  • To improve the interpretation of genome-wide screen findings in disease research.
  • To uncover novel connections and functional modules involved in disease etiology.

Main Methods:

  • Utilizing Bayesian statistics to group co-regulated genes from microarray data.
  • Incorporating external molecular interaction data as priors for group assignments.
  • Employing Markov chain Monte Carlo (MCMC) sampling for reliable grouping.

Main Results:

  • Simulations demonstrated improved group identification accuracy compared to traditional clustering, particularly with small sample sizes.
  • Application to a heart failure dataset identified clusters related to extracellular matrix and carbohydrate metabolism.
  • Analysis of a melanoma dataset revealed a main cluster associated with keratinocyte differentiation.

Conclusions:

  • The developed method successfully identified clusters overlapping with known pathogenic processes.
  • The approach also highlighted novel molecular connections extending beyond classical disease pathways.
  • This facilitates a deeper understanding of molecular mechanisms in disease.